| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| acute myeloid leukemia stem cell transplant | 0.65 | 0.7 | 5379 | 65 | 43 |
| acute | 1.55 | 0.5 | 4412 | 44 | 5 |
| myeloid | 0.74 | 0.6 | 5999 | 4 | 7 |
| leukemia | 1.84 | 0.8 | 7091 | 47 | 8 |
| stem | 0.37 | 0.8 | 8465 | 74 | 4 |
| cell | 1.05 | 0.3 | 9335 | 98 | 4 |
| transplant | 1.77 | 0.2 | 2269 | 70 | 10 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| acute myeloid leukemia stem cell transplant | 1.81 | 0.8 | 8290 | 23 |
| acute myeloid leukemia bone marrow transplant | 0.08 | 0.6 | 9494 | 47 |
| acute myeloid leukemia stem cell treatment | 1.18 | 0.3 | 8387 | 7 |
| acute myeloid leukemia stem cells | 0.96 | 0.5 | 1384 | 36 |
| stem cell transplant for aml leukemia | 1.91 | 0.6 | 9655 | 54 |
| leukemia stem cell transplant | 1.07 | 0.9 | 8203 | 53 |
| stem cell transplant for leukemia patients | 0.75 | 0.8 | 3862 | 47 |
| leukemia and stem cell transplant | 1.06 | 0.6 | 7849 | 19 |
| stem cell transplant for all leukemia | 0.39 | 0.1 | 5227 | 95 |
| acute myeloid leukemia blood transfusion | 0.13 | 0.3 | 2920 | 50 |
| stem cell transplant for aml | 1.46 | 0.2 | 7645 | 46 |
| stem cell transplantation for leukemia | 0.07 | 0.2 | 4534 | 60 |
| acute leukemia bone marrow transplant | 0.73 | 0.3 | 9656 | 30 |
| stem cell transplants for leukemia | 1.23 | 0.7 | 7266 | 26 |
| aml and stem cell transplant | 0.13 | 0.8 | 2583 | 100 |
| acute myeloid leukemia translocation | 1.7 | 0.3 | 4128 | 97 |
| myeloablative stem cell transplant | 1.68 | 0.4 | 8285 | 61 |
| myeloma and stem cell transplant | 0.06 | 1 | 2931 | 67 |
| myeloma stem cell transplant | 0.17 | 1 | 5868 | 1 |
| stem cell transplants for aml | 0.99 | 0.3 | 4948 | 70 |
Acute myeloid leukaemia (AML) is caused by a DNA mutation in the stem cells in your bone marrow that produce red blood cells, platelets and infection-fighting white blood cells. The mutation causes the stem cells to produce many more white blood cells than are needed. The white blood cells produced are still immature, so they do not have the infection-fighting properties of fully developed white blood cells.
How is acute myeloid leukemia treated?The trial, for treatment of patients suffering from relapse/refractory Acute Myeloid Leukemia (AML), OmnImmune® comprises GDT cells sourced from healthy donors, expanded and activated in large numbers before being purified and formulated for infusion into patients. OmnImmune® is a frozen and thawed product, now "banked" from donor derived cells.
Is acute myeloid leukemia curable?Though serious for many, especially patients over age 60, AML is treatable and potentially curable for younger people and those with certain disease subtypes. This article will explain acute myeloid leukemia's survival rate and outlook and highlight the nuances of how they are affected by age, AML type, and treatment response.
What is acute myeloid leukaemia?Acute myeloid leukemia is a complicated heterogenous hematological cancer with a poor prognosis, but novel targets may lead to improved treatment and outcomes going forward. Patients with acute myeloid leukemia (AML) currently face a poor prognosis and ...
